Kidney injury molecule-1 is involved in the chemotactic migration of mesenchymal stem cells
详细信息 查看全文
- 作者：Kyung-Mee Park (1) (2)
Hyun-Suk Nam (1) (2)
Pankaj Kumar Teotia (1) (2)
Kamal Hany Hussein (1) (2)
Seok-Ho Hong (1) (3)
Jung-Im Yun (1)
Heung-Myong Woo (1) (2) (4) - 关键词：KIM ; 1 ; MSCs ; CXCR4 ; Migration ; TNF ; α
- 刊名：In Vitro Cellular & Developmental Biology - Animal
- 出版年：2014
- 出版时间：August 2014
- 年：2014
- 卷：50
- 期：7
- 页码：648-655
- 全文大小：2,164 KB
- 参考文献：1. Baek SJ, Kang SK, Ra JC (2011) In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43:596-03 CrossRef
2. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV (2002) Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277:39739-9748 CrossRef
3. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-496 CrossRef
4. Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3265-268 CrossRef
5. Broekema M, Harmsen MC, Koerts JA, Petersen AH, van Luyn MJ, Navis G, Popa ER (2005) Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats. Kidney Int 68:2572-581 CrossRef
6. Burst VR, Gillis M, Putsch F, Herzog R, Fischer JH, Heid P, Muller-Ehmsen J, Schenk K, Fries JW, Baldamus CA, Benzing T (2010) Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 114:e107–e116 CrossRef
7. Bussolati B, Tetta C, Camussi G (2008) Contribution of stem cells to kidney repair. Am J Nephrol 28:813-22 CrossRef
8. Cai L, Johnstone BH, Cook TG, Tan J, Fishbein MC, Chen PS, March KL (2009) IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 27:230-37 CrossRef
9. Egea V, von Baumgarten L, Schichor C, Berninger B, Popp T, Neth P, Goldbrunner R, Kienast Y, Winkler F, Jochum M, Ries C (2011) TNFalpha respecifies humanmesenchymal stemcells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ 18:853-63 CrossRef
10. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg ME (2006) Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 17:3028-040 CrossRef
11. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-44 CrossRef
12. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G (2007) Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430-41 CrossRef
13. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-041 CrossRef
14. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV (2008) Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118:1657-668 CrossRef
15. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV (2004) Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Ren Physiol 286:F552–F563
16. Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-928 CrossRef
17. Ji JF, He BP, Dheen ST, Tay SS (2004) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-27 CrossRef
18. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613-617 CrossRef
19. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J (2007) The in vitro migration capacity of human bone marrowmesenchymal stemcells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-745 CrossRef
20. Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun JA, Oh JH, Park SH, Oh WI, Jeun SS (2010) Migration of human umbilical cord bloodmesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun 398:105-10 CrossRef
21. Semedo P, Palasio CG, Oliveira CD, Feitoza CQ, Goncalves GM, Cenedeze MA, Wang PM, Teixeira VP, Reis MA, Pacheco-Silva A, Camara NO (2009) Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 9:677-82 CrossRef
22. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, Lieberthal W (1993) Renal mouse proximal tubular cells are more susceptible thanMDCK cells to chemical anoxia. Am J Physiol 265:F342–F350
23. Song JS, Kang CM, Kang HH, Yoon HK, Kim YK, Kim KH, Moon HS, Park SH (2010) Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med 42:465-72 CrossRef
24. Sung JH, Yang HM, Park JB, Choi GS, Joh JW, Kwon CH, Chun JM, Lee SK, Kim SJ (2008) Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc 40:2649-654 CrossRef
25. Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C (2009) Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18:475-85 CrossRef
26. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Ren Physiol 289:F31–F42 - 作者单位：Kyung-Mee Park (1) (2)
Hyun-Suk Nam (1) (2)
Pankaj Kumar Teotia (1) (2)
Kamal Hany Hussein (1) (2)
Seok-Ho Hong (1) (3)
Jung-Im Yun (1)
Heung-Myong Woo (1) (2) (4)
1. Stem Cell Institute-KNU, Kangwon National University, Chuncheon, 200-701, South Korea
2. College of Veterinary Medicine, Kangwon National University, Chuncheon, South Korea
3. College of Medicine, Kangwon National University, Chuncheon, South Korea
4. Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA - ISSN：1543-706X
文摘
A better understanding of the organ specific factors that regulate the migration of mesenchymal stem cells (MSCs) into the target organ is essential for optimization of strategies to improve the repair after injury. In the present study, we showed that the kidney injury molecule-1 (KIM-1), a well-known kidney-specific biomarker, enhanced the in vitro migration capacity of MSCs as a potent kidney-specific chemo-attractant or an inducer. The in vitro roles were verified by migration assay using KIM1-PK1 cell lines, the mouse proximal tubular epithelial cells (mPTEs) and recombinant human KIM-1 proteins (rhKIM-1). Immunofluorescence staining displayed specific ectodomain binding of KIM-1 on the surface of MSCs. Upregulation of chemokine receptor type 4 (CXCR4) protein when treated with tumor necrosis factor alpha (TNF-α) was shown. The effect of KIM-1 on migration of MSCs was augmented by TNF-α pretreatment in a dose-dependent manner, and reduced by AMD3100, an antagonist of CXCR4. These results suggest that KIM-1 is a potential chemo-ligand of CXCR4 and may play an important role in kidney-specific migration of MSCs via interaction between KIM-1 and CXCR4.